These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27461827)

  • 21. Persistence of HPV after radio-chemotherapy in locally advanced cervical cancer.
    Badaracco G; Savarese A; Micheli A; Rizzo C; Paolini F; Carosi M; Cutillo G; Vizza E; Arcangeli G; Venuti A
    Oncol Rep; 2010 Apr; 23(4):1093-9. PubMed ID: 20204296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral load of human papillomavirus in women with normal and abnormal cervical cytology in Kuwait.
    Al-Awadhi R; Chehadeh W; Al-Jassar W; Al-Harmi J; Al-Saleh E; Kapila K
    J Infect Dev Ctries; 2013 Feb; 7(2):130-6. PubMed ID: 23416659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus genotype as a major determinant of the course of cervical cancer.
    Lombard I; Vincent-Salomon A; Validire P; Zafrani B; de la Rochefordière A; Clough K; Favre M; Pouillart P; Sastre-Garau X
    J Clin Oncol; 1998 Aug; 16(8):2613-9. PubMed ID: 9704710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression and significance of P16INK4A and PTEN in high-risk human papillomavirus-related cervical cancer].
    Zhao XL; Cheng SX; Kong XD
    Ai Zheng; 2007 May; 26(5):480-3. PubMed ID: 17672936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
    Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
    J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of xunxi no.1 intervention and radiotherapy on Ia-IIb stage cervical cancer with high-risk human papilloma virus infection].
    Zhang PY; Liu L; Wang XB
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Aug; 31(8):1066-9. PubMed ID: 21910336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix.
    Wang CC; Lai CH; Huang YT; Chao A; Chou HH; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e499-506. PubMed ID: 22889667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration Pattern of Human Papillomavirus Is a Strong Prognostic Factor for Disease-Free Survival After Radiation Therapy in Cervical Cancer Patients.
    Joo J; Shin HJ; Park B; Park SY; Yoo CW; Yoon KA; Kong SY; Kim YJ; Kim SS; Kim JY
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):654-661. PubMed ID: 28581408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
    Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F
    Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus prevalence in postradiotherapy uterine cervical carcinoma patients: correlation with recurrence of the disease.
    Singh RK; Maulik S; Mitra S; Mondal RK; Basu PS; Roychowdhury S; Panda CK
    Int J Gynecol Cancer; 2006; 16(3):1048-54. PubMed ID: 16803484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status.
    Dürst M; Hoyer H; Altgassen C; Greinke C; Häfner N; Fishta A; Gajda M; Mahnert U; Hillemanns P; Dimpfl T; Lenhard M; Petry KU; Runnebaum IB; Schneider A
    Oncotarget; 2015 Sep; 6(26):23015-25. PubMed ID: 26008982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV viral load determination during pregnancy as a possible cervical cancer risk.
    Bandyopadhyay S; Chatterjee R
    J Exp Clin Cancer Res; 2006 Mar; 25(1):29-38. PubMed ID: 16761615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased human papillomavirus viral load is correlated to higher severity of cervical disease and poorer clinical outcome: A systematic review.
    Fobian SF; Mei X; Crezee J; Snoek BC; Steenbergen RDM; Hu J; Ten Hagen TLM; Vermeulen L; Stalpers LJA; Oei AL
    J Med Virol; 2024 Jun; 96(6):e29741. PubMed ID: 38922964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV- and node status in cervical cancer long-term results.
    Póka R; Czeglédy J
    Eur J Obstet Gynecol Reprod Biol; 1997 Feb; 71(2):169-72. PubMed ID: 9138961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic characterization of cervical cancer based on human papillomavirus status.
    Zhang L; Jiang Y; Lu X; Zhao H; Chen C; Wang Y; Hu W; Zhu Y; Yan H; Yan F
    Gynecol Oncol; 2019 Mar; 152(3):629-637. PubMed ID: 30581036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA.
    Higgins GD; Davy M; Roder D; Uzelin DM; Phillips GE; Burrell CJ
    Lancet; 1991 Oct; 338(8772):910-3. PubMed ID: 1681267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early posttherapy clearance of human papillomavirus and treatment response in cervical carcinoma.
    Srivastava AJ; Contreras JA; Davis M; Markovina ST; Schwarz JK; Grigsby PW
    Cancer; 2020 Sep; 126(18):4168-4176. PubMed ID: 32639597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low Necroptosis Process Predicts Poor Treatment Outcome of Human Papillomavirus Positive Cervical Cancers by Decreasing Tumor-Associated Macrophages M1 Polarization.
    Li L; Yu S; Zang C
    Gynecol Obstet Invest; 2018; 83(3):259-267. PubMed ID: 29621771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of negative conversion of high-risk Human Papillomavirus DNA after treatment in Cervical Cancer patients.
    Chen Q; Shi R; Liu Z; Shi Z; Gu K; Chen J; He Y; Li Y; Wu J; Ji S; Zhou J; Zhu J
    J Cancer; 2020; 11(20):5911-5917. PubMed ID: 32922533
    [No Abstract]   [Full Text] [Related]  

  • 40. Surrogate endpoint biomarkers and their modulation in cervical chemoprevention trials.
    Follen M; Schottenfeld D
    Cancer; 2001 May; 91(9):1758-76. PubMed ID: 11335902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.